| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Psa5g0135 | ATGTCCGGACCCCTCGATCGTTTCGCAATGCCTTGTTTTGAGGGGTTTTCCGGCAGTGATGACAAGAGAGAACGGAGATCTGATTTTGAGAACTCTGAAGATGAAAGGAGAACCAGAATTGGATCTCTGAAAAAGAAAGCGATTAATGCTTCCACTAAATTCAAGCATTCTCTTAGGAAGAAGAGTGGCAGGAGAAAGAGTGATGGACGTGTTAGCTCTGTTTCGATTGAGGATATTCGGGATGTGGAAGAGCTTCAAGCTGTCGATGGTTTTCGCCAGTCGTTGATCATGGATGAGTTGCTTCCTGATACTTTTGATGATTATCATATGATGTTAAGATTTTTGAAAGCGAGGAAATTTGATATTGAAAAAGCTAAGCATATGTGGGCTGACATGCTACAATGGAGGAGAGAGTTTGGTGCTGACACCATTATGCAGGATTTTGAGTTCAAAGAGTTAAATGAAGTTGTGAAATATTACCCACATGGCCATCATGGTGTAGATAGGGAGGGAAGGCCTGTGTATATTGAAAGGCTTGGAAAAGTTGATCCGAACAAGCTTATGCAAGTTACAACTATGGATAGATATGTAAAGTACCACGTGCAAGAGTTTGAGAAATCTTTTGCAATAAAGTTTCCTGCTTGCACTATTGCTGCCAAGAGGCACATAGATTCAAGCACCACAATCTTAGATGTTCAAGGAGTGGGGCTTAAGAATTTTACTAAGTCAGCCCGGGATCTCGTCATGCGATTGCAGAAGGTCGAGGTGACAATTACCCTGAGACACTCTGCCAAATGTTTATTATAA | 807 | 0.4164 | MSGPLDRFAMPCFEGFSGSDDKRERRSDFENSEDERRTRIGSLKKKAINASTKFKHSLRKKSGRRKSDGRVSSVSIEDIRDVEELQAVDGFRQSLIMDELLPDTFDDYHMMLRFLKARKFDIEKAKHMWADMLQWRREFGADTIMQDFEFKELNEVVKYYPHGHHGVDREGRPVYIERLGKVDPNKLMQVTTMDRYVKYHVQEFEKSFAIKFPACTIAAKRHIDSSTTILDVQGVGLKNFTKSARDLVMRLQKVEVTITLRHSAKCLL* | 269 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Psa5g0135 | 268 | Pfam | CRAL/TRIO domain | 159 | 248 | IPR001251 | - | |
| Psa5g0135 | 268 | SUPERFAMILY | CRAL/TRIO domain | 152 | 253 | IPR036865 | - | |
| Psa5g0135 | 268 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 82 | 148 | IPR036273 | - | |
| Psa5g0135 | 268 | MobiDBLite | consensus disorder prediction | 1 | 42 | - | - | |
| Psa5g0135 | 268 | CDD | SEC14 | 150 | 254 | IPR001251 | - | |
| Psa5g0135 | 268 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 152 | 268 | IPR001251 | - | |
| Psa5g0135 | 268 | Gene3D | - | 140 | 255 | IPR036865 | - | |
| Psa5g0135 | 268 | SMART | CRAL_TRIO_N_2 | 107 | 132 | IPR011074 | - | |
| Psa5g0135 | 268 | Gene3D | - | 76 | 139 | - | - | |
| Psa5g0135 | 268 | Pfam | CRAL/TRIO, N-terminal domain | 109 | 131 | IPR011074 | - | |
| Psa5g0135 | 268 | PANTHER | PHOSPHATIDYLINOSITOL/PHOSPHATIDYLCHOLINE TRANSFER PROTEIN SFH8 | 3 | 255 | - | - | |
| Psa5g0135 | 268 | MobiDBLite | consensus disorder prediction | 17 | 42 | - | - | |
| Psa5g0135 | 268 | PANTHER | CRAL-TRIO DOMAIN-CONTAINING PROTEIN YKL091C-RELATED | 3 | 255 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Psa5g0135 | Psa-Chr5 | 8053364 | 8054842 | Proximal |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Psa5g0135 | 86 | 242 | Acyl Lipid Metabolism Gene Families | AT5G47730 | 26.786 | 4.80e-07 | 48.5 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Psa5g0135 | - | - | mnt:21392105 | 465.692 |